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Introduction: Pulmonary Tuberculosis (PTB) is one of the major diseases of public health importance 
especially in prisons where case finding rate has been low. The WHO established five facts of prisons PTB 
spread which include: Prisons receive TB, Prisons concentrate TB, Prisons disseminate TB, Prisons make TB 
worse, and Prisons export TB. Poor TB case finding result in annual TB transmission risks of 90%. This study 
determined the prevalence of pulmonary tuberculosis among inmates and staff of Nigerian Prisons, Abakaliki 
 
Methods: A prison-based cross-sectional descriptive study was undertaken among 307 inmates and staff 
selected using a systematic sampling technique. Informed consent was obtained from the staff and inmates. The 
respondents were interviewed using a pre-tested interviewer administered structured questionnaire. GeneXpert 
test was done for respondents with cough of two weeks or more. Data analysis was done using SPSS statistical 
software version 22. Chi squared test was used for bivariate analysis and level of significance was set at a p-
value of less than 0.05. Results were treated with strict confidentiality. 
 
Results: The mean age of inmates was 34.96±5.7 years while staff was 38.43±3.5 years. Majority had 
secondary education. GeneXpert test result revealed 2.0% prevalence of PTB among suspected inmates, 1.1% 
among all inmates and 2.8% among staff. Prevalence of TB was associated with age group of both inmates and 
staff and duration of stay of inmates only.   
 
Conclusion: This study found moderate prevalence of tuberculosis among inmates and prison staff in Abakaliki 
prison. Although this prevalenceis moderate, it is imperative that periodic screening of old inmates and newly 
introduced ones be practiced so as to minimize the burden of tuberculosis among prisoners. Implementation of 
current national or international cell occupancy recommendations would reduce TB transmission by 50% and 
94% respectively especially now that there is increase in the incidence of MDR-TB. 
 










uberculosis (TB) in penitentiary 
services (prisons) is a major 
challenge to TB control
1
. 
Pulmonary Tuberculosis (PTB) is one of 
the major diseases of public health 
importance especially in prisons where 
case finding rate has been low and remains 
a major public health problem, posing 
specific challenges in numerous 
geographical areas, particularly in low- 
and middle-income countries (LMICs) 
where more than 80% of the global TB 
burden resides
1
. The WHO established 
five facts of prisons PTB spread which 
include: Prisons receive TB, Prisons 
concentrate TB, Prisons disseminate TB, 
Prisons make TB worse, and Prisons 




annual TB transmission risks of 90%
1
. 
Despite recently gained increased public 
and political awareness, TB still remains a 
major infectious disease in prison systems 
for several reasons. These include but are 
not limited to the high prevalence of drug-
resistant TB forms such as multi- and 
extensively drug-resistant TB (M/XDR-
TB)
1-13
, and intravenous drug use among 
HIV-infected individuals, which makes 
prison populations more susceptible to the 
development of TB
14
. Prisons are 
considered reservoirs promoting 
transmission of Mycobacterium 
Tuberculosis (MTB) within their walls, as 
well as to the community at large. 
Transmission occurs through prison staff, 
visitors, and released inmates. The 
estimated prevalence of latent TB infection 
(LTBI) and active TB disease in LMICs 
such as Ethiopia, Thailand and Brazil, 
where TB prevalence has been reported to 
be almost 4-, 8-, and 64-times respectively 
higher among prisoners compared to the 
general population
15,16
. Factors known to 
contribute to the transmission of MTB 
strains and that hamper TB control are 
overcrowding, delayed case detection, 
poor contact detection, inadequate 
treatment of infectious cases, high 
turnover of prisoners, and poor 
implementation of TB infection control 
(IC) measures
17,18
. In addition, limited 
access to timely and quality health care 
services further exacerbate the situation. 




the prisons suffer from severe 
overcrowding, poor hygiene and 
inadequate ventilation, representing an 
epicentre for transmission of TB to close 
contacts and surrounding communities. 
Often there is no medical screening upon 
admission, and TB-infected prisoners are 
housed in crowded cells. Thus, the 
integration of a prison TB control 
programme into the national TB 
programme should be given priority. 
Adequate information is needed about 
prisoners’ awareness and practice 
regarding TB.  
 
TB control could be significantly 
improved if more consideration was given 
to the population’s knowledge and 
attitudes about TB and related health care-
seeking behaviour
20
 by directing efforts 
towards making individuals more 
informed and aware of all aspects of TB, 
its treatment, and basic rules for 
preventing the spread of the disease to 
close contacts (community and family 
members, prison staff, inmates, and others 
who have social or physical contact with 
TB patients). 
 
In response to the continuing challenges 
facing the control of TB and M/XDR-TB, 
and as the current Global Plan to Stop TB 
(Stop TB Strategy) 2011–2015, the World 
Health Organization (WHO) has recently 
developed the End TB Strategy with the 
goal to end the TB epidemic by 2035
21
. As 
such this study determined the prevalence 
of pulmonary tuberculosis among inmates 
and staff of Nigerian Prisons, Abakaliki 
 
MATERIALS/METHODS  
Study area and design: A cross-sectional 
study was conducted at Abakaliki Prisons 
(the largest prisons in Ebonyi State, 
Nigeria) from June, 2017 to August, 2017. 
It was purposively selected. The prison has 
a clinic that follows the health status of the 
prisoners and refers cases like tuberculosis 
to Federal Teaching Hospital Abakaliki 
(FETHA) for confirmation and initiation 
of treatment.  
 
Study subjects and sampling technique: 
Study subjects were selected using 
systematic sampling technique from the 
 
 
total population (n = 516) based on 
established criteria for describing the 
prevalence of PTB. These included cough 
for ⩾2 weeks, taking anti-tuberculosis 
treatment for PTB during the study period 
and consent to participate in the study. In 
all, 307 (59.5%) inmates who fulfilled the 
selection criteria were included in the 
study.  
 
Data collection: A structured interviewer 
administered questionnaire was used to 
collect data on socio-demographic 
information, signs and symptoms of TB 
among respondents.  
 
Sputum collection and GeneXperttest: 
Sputum samples of study participants were 
collected in clean, dry tightly capped 
containers. The samples were immediately 
taken to FETHA Laboratory for 
appropriate examination and analysis. 
Results were observed and interpreted by 
two laboratory scientists to ensure their 
validity  
 
Data analysis: Data were analyzed using 
SPSS version 22. Mean and percentages 
were used to summarize the results. Chi-
square test was done to assess significant 
associationbetween prevalence of 
tuberculosis and inmate’s and staff’s 
socio-demographic variables. A 
significance level was set at a p-value less 
than 0.05.  
 
Ethical considerations: The ethical 
approval was obtained from the research 
and ethics committee of Ebonyi State 
Ministry of Health.  Informed consent was 
given by the study participants. 
Participants were assured of 
confidentiality. Inmates who were found 
positive were enrolled into the directly 
observed short course treatment protocol. 
Results: The mean age of inmates was 
34.96±5.7 years while staff was 38.43±3.5 
years. Majority had secondary education. 
This study found 2.0% point prevalence of 
PTB by GeneXperttest among suspected 
inmates, 1.1% among all inmates and 2.8% 
among staff  
 
Table 1: Socio-demographic profile of respondents (N= 307 for Inmates), (N=69 for 
Staff) 
Variables Inmates, n (%) Staff, n (%) Total, N=376 (%) 
 
P-value 
Sex     
Male 286 (93.2) 53 (76.8) 339 (90.2) <0.001 
Female 21 (6.8) 16 (23.2) 37 (9.8)  
Age (years)     
18-49 284 (92.5) 64 (92.8) 348 (92.6) 0.94 
≥50 23 (7.5) 5 (7.2) 28 (7.4)  
Educational status     
<Secondary 63 (20.5) 4 (5.8) 67 (17.8) 0.02 
 ≥Secondary 244 (79.5) 65 (94.2) 309 (82.2)  
Occupation     
Government employees 59 (19.2) 69 (100) 128 (34.0) FT0.03 
Non-government 
employees 
248(80.8) 0 (0) 248(66.0)  
Duration of stay     
≤ 1 year 167 (54.4) 5 (7.2) 172 (45.7) <0.05 
>1 year 140 (45.6) 64 (92.8) 204 (54.3)  
Mean age (inmates) = 34.96±5.7 years  
Mean age (staff) = 38.43±3.5 years  
 
 






  Inmates (N=307) Staff (N=69) 










Sex       
Male 5 (1.6) 281 (91.6) 0.33 2 (2.9) 51 (73.9) FT (0.06) 
Female 1 (0.3) 20 (6.5)  0 (0) 16 (23.2)  
Age (years)       
18-49 4 (1.3) 280 (91.2) FT(0.01) 1 (1.4) 63 (91.4) FT (0.02) 
≥50 2 (0.7) 21 (6.8)  1 (1.4) 4 (5.8)  
Residence       
Urban 1 (0.3) 113 (36.8) 0.29 0 (0) 58 (84.1) FT (0.11) 
Rural 5 (1.6) 188 (61.3)  2 (2.9) 9 (13.0)  
Educational status       
<Secondary 2 (0.7) 61 (19.9) FT(0.31) 0 (0) 4 (5.8) FT (0.09) 
≥Secondary 4 (1.3) 240 (78.1)  2 (2.9) 63 (91.3)  
Occupation       
Government 
employees 
1 (0.3) 58 (18.9) 0.30 2 (2.9) 67 (97.1) FT(0.12) 
Non-government 
employees 
5 (1.6) 243 (79.2)  0 (0) 0 (0)  
Previous contact 
with TB patient 
      
Yes 5 (1.6) 140 (45.7) 0.07 2 (2.9) 10 (14.5) FT (0.06) 
No 1(0.3) 161 (52.4)  0 (0) 57 (82.6)  
Duration of stay       
≤ 1 year 2 (0.7) 210 (68.4) FT(0.04) 0 (0) 5 (7.2) FT (0.07) 
>1 year 4 (1.3) 91 (29.6)  2 (2.9) 62 (89.9)  
 FT=Fisher’s exact test 
 
Risk factor assessment: Almost all the 
risk factors assessed  except age of inmates 
and staff, and duration of prison stay by 
inmates,  did not show statistically 
significant association with the prevalence 
of tuberculosis among respondents. 
 
DISCUSSION  
Although the recommended international 
cell occupancy was not exceeded, the 
Nigerian prisons Abakaliki was relatively 
congested as at the time of this study. This 
may be largely due to the fact that it serves 
the entire State and its environs. The 2.0% 
prevalence of PTB by GeneXpert test 
among suspected inmates, 1.1% among all 
inmates and 2.8% among staff is higher 
than the 0.9% found in the Multi centre 
prisons study in Nigerian prisons
22
 and the 
0.7% found among TB suspected inmates 
in Malawi
23
. The difference may be 
attributed to the methods employed in the 
selection of study participants; the 
Malawian study recruited prisoners with 
cough history of one week and above 
which may cause decreased case detection 
and increased sample size, but this study 
included only individuals with cough of 
two weeks duration or more. It is however 







.  This difference may largely 
be attributed to the selection criteria of 
patients in Brazilian study which included 
prisoners with cough duration of greater 
than three weeks only. That made the 
sample size very small resulting in a low 
prevalence rate. The 2.0% prevalence rate 
found among inmates in this study is still 
lower than the 8.9% in Eastern 
Ethiopia
16
and 10.4% in other place
26 
. This 
study also found 1.1% prevalence rate 
among the general inmates. The lower TB 
prevalence in this study might be also 
associated with the precautionary 
measures by the general public in Nigeria. 
The1.1% prevalence is at variance with the 
2.0% reported in Gondar prisons
25 
.That 
high rate was expected to be attributable in 
large part to the high concentration of risk 
factors for tuberculosis in incoming 
prisoners, including HIV infection, a 
history of intravenous drug use, low 
socioeconomic status, malnutrition, 
homelessness, and inability to access 
community-based health care. Other risk 
factors included poor ventilation and 
overcrowding which promote transmission 




Tuberculosis in prisons encompasses not 
only TB among prisoners, but also prison 
staff that ultimately interacts directly with 
their families and community when they 
leave work
28 
. The 2.8% prevalence rate 
reported among the prison staff in this 
study is high when compared to the 0.53% 
among prison staff in Ethiopia
29 
.There 
was significant association between 
prevalence of TB and duration of prison 
stay for more than 1 year. This may be 
possible because new cases of tuberculosis 
positive prisoners are being introduced to 
the prison. This situation on the other hand 
may contribute to the increased prevalence 
of tuberculosis in the general population as 
those prisoners released may transmit the 
infection. The results of this study indicate 
the importance of initial screening of 
newly introduced prisoners to the prisons. 
More over periodic screening is also 





The sensitivity and specificity of this study 
was limited by its inability to investigate 
TB-HIV co-infected inmates and staff and 
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